U.S. court imposes temporary sales ban on Dr Reddy's generic Nexium

MUMBAI, Nov 10 (Reuters) - Dr Reddy's Laboratories Ltd , India's second-largest drugmaker by sales, said on Tuesday it had been temporarily barred by a U.S. court from selling its generic form of blockbuster heartburn drug Nexium in the United States.